Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Neo-T

Aliases
Neoantigen targeting T cells Suspension for Intravenous Infusion

2 clinical trials

1 indication

Indication
Solid Tumor
Clinical trial
The Neoantigen Targeting T Cells Suspension for Intravenous Infusion(Neo-T) in Treating Patients With Advanced Solid Tumor
Status: Recruiting, Estimated PCD: 2023-09-01
Clinical trial
The Safety,Tolerance and Efficacy of Neoantigen Targeting T Cells Suspension for Intravenous Infusion(Neo-T) to Advanced Solid Tumor
Status: Recruiting, Estimated PCD: 2023-09-01